Hyaluronic acid synthesis operon (has) expression in group A streptococci.

PubWeight™: 1.81‹?› | Rank: Top 3%

🔗 View Article (PMID 7629171)

Published in J Biol Chem on August 04, 1995

Authors

D L Crater1, I van de Rijn

Author Affiliations

1: Wake Forest University Medical Center, Winston-Salem, North Carolina 27157, USA.

Articles citing this

Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35

A response regulator that represses transcription of several virulence operons in the group A streptococcus. J Bacteriol (1999) 3.81

A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect Immun (1999) 3.15

Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol (2011) 2.81

Role of mga in growth phase regulation of virulence genes of the group A streptococcus. J Bacteriol (1997) 2.20

Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev (2014) 2.20

Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus. Infect Immun (1997) 2.13

Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. J Clin Invest (1998) 1.87

Rgg influences the expression of multiple regulatory loci to coregulate virulence factor expression in Streptococcus pyogenes. Infect Immun (2002) 1.78

Glucose-related dissociation between icaADBC transcription and biofilm expression by Staphylococcus epidermidis: evidence for an additional factor required for polysaccharide intercellular adhesin synthesis. J Bacteriol (2003) 1.47

M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus. MBio (2010) 1.47

Capsule biosynthesis and basic metabolism in Streptococcus pneumoniae are linked through the cellular phosphoglucomutase. J Bacteriol (2000) 1.42

Distinct signatures of diversifying selection revealed by genome analysis of respiratory tract and invasive bacterial populations. Proc Natl Acad Sci U S A (2011) 1.39

Natural disruption of two regulatory networks in serotype M3 group A Streptococcus isolates contributes to the virulence factor profile of this hypervirulent serotype. Infect Immun (2014) 1.36

Characterization of the galU gene of Streptococcus pneumoniae encoding a uridine diphosphoglucose pyrophosphorylase: a gene essential for capsular polysaccharide biosynthesis. J Exp Med (1998) 1.35

CD44 as a receptor for colonization of the pharynx by group A Streptococcus. J Clin Invest (2000) 1.30

Hyaluronic acid production in Bacillus subtilis. Appl Environ Microbiol (2005) 1.26

Molecular analysis of the capsule gene region of group A Streptococcus: the hasAB genes are sufficient for capsule expression. J Bacteriol (1998) 1.26

Role of hyaluronidase in subcutaneous spread and growth of group A streptococcus. Infect Immun (2006) 1.23

Molecular analysis of the Enterococcus faecalis serotype 2 polysaccharide determinant. J Bacteriol (2003) 1.14

Two capsular polysaccharides enable Bacillus cereus G9241 to cause anthrax-like disease. Mol Microbiol (2011) 1.11

Identification and disruption of two discrete loci encoding hyaluronic acid capsule biosynthesis genes hasA, hasB, and hasC in Streptococcus uberis. Infect Immun (2001) 1.11

Growth-phase-dependent expression of virulence factors in an M1T1 clinical isolate of Streptococcus pyogenes. Infect Immun (1999) 1.09

Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules. FEMS Microbiol Rev (2014) 1.05

Role of group A streptococcal virulence factors in adherence to keratinocytes. Infect Immun (2000) 1.03

The capsular polysaccharide of Staphylococcus aureus is attached to peptidoglycan by the LytR-CpsA-Psr (LCP) family of enzymes. J Biol Chem (2014) 0.95

The sweet tooth of bacteria: common themes in bacterial glycoconjugates. Microbiol Mol Biol Rev (2014) 0.91

Complete genome sequence and immunoproteomic analyses of the bacterial fish pathogen Streptococcus parauberis. J Bacteriol (2011) 0.90

Role of CsrR, hyaluronic acid, and SpeB in the internalization of Streptococcus pyogenes M type 3 strain by epithelial cells. Infect Immun (2002) 0.87

Spread of a highly mucoid Streptococcus pyogenes emm3/ST15 clone. BMC Infect Dis (2010) 0.86

Transcription of the Streptococcus pyogenes hyaluronic acid capsule biosynthesis operon is regulated by previously unknown upstream elements. Infect Immun (2014) 0.85

Thermoregulation of capsule production by Streptococcus pyogenes. PLoS One (2012) 0.85

CpsY influences Streptococcus iniae cell wall adaptations important for neutrophil intracellular survival. Infect Immun (2012) 0.84

A conserved UDP-glucose dehydrogenase encoded outside the hasABC operon contributes to capsule biogenesis in group A Streptococcus. J Bacteriol (2012) 0.82

Strategies in the development of vaccines to prevent infections with group A streptococcus. Hum Vaccin Immunother (2013) 0.80

UDP-glucose pyrophosphorylase: up-regulation in hypertrophic cartilage and role in hyaluronan synthesis. Biochem J (2001) 0.80

Retargeting pre-existing human antibodies to a bacterial pathogen with an alpha-Gal conjugated aptamer. J Mol Med (Berl) (2015) 0.78

Genetic basis for hyper production of hyaluronic acid in natural and engineered microorganisms. Microb Cell Fact (2016) 0.77

StreptoBase: An Oral Streptococcus mitis Group Genomic Resource and Analysis Platform. PLoS One (2016) 0.76

Abundance and co-occurrence of extracellular capsules increases environmental breadth: Implications for the emergence of pathogens. PLoS Pathog (2017) 0.75

The Regulatory Small RNA MarS Supports Virulence of Streptococcus pyogenes. Sci Rep (2017) 0.75

Articles by these authors

Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun (1980) 5.90

Group A streptococcal antigens cross-reactive with myocardium. Purification of heart-reactive antibody and isolation and characterization of the streptococcal antigen. J Exp Med (1977) 3.80

Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med (1976) 2.98

Nutritionally variant streptococci from patients with endocarditis: growth parameters in a semisynthetic medium and demonstration of a chromophore. J Bacteriol (1981) 2.17

Lysis of grouped and ungrouped streptococci by lysozyme. Infect Immun (1970) 2.09

Characterization of a two-component system in Streptococcus pyogenes which is involved in regulation of hyaluronic acid production. J Biol Chem (1999) 1.90

Molecular characterization of hasB from an operon required for hyaluronic acid synthesis in group A streptococci. Demonstration of UDP-glucose dehydrogenase activity. J Biol Chem (1993) 1.78

Immunochemical analysis of intact M protein secreted from cell wall-less streptococci. Infect Immun (1981) 1.62

Molecular characterization of hasA from an operon required for hyaluronic acid synthesis in group A streptococci. J Biol Chem (1994) 1.54

Molecular characterization of a locus required for hyaluronic acid capsule production in group A streptococci. J Exp Med (1992) 1.39

The occurrence of a protein in the extracellular products of streptococci isolated from patients with acute glomerulonephritis. J Exp Med (1979) 1.31

Characterization and localization of the enzymatic deacylation of lipoteichoic acid in group A streptococci. J Exp Med (1979) 1.29

Immunochemical study of nutritionally variant streptococci. J Immunol (1984) 1.28

Characterization of a pH-dependent chromophore from nutritionally variant streptococci. Infect Immun (1984) 1.27

Synthesis of 5-azido-UDP-N-acetylhexosamine photoaffinity analogs and radiolabeled UDP-N-acetylhexosamines. Anal Biochem (1998) 1.26

Streptococcal hyaluronic acid: proposed mechanisms of degradation and loss of synthesis during stationary phase. J Bacteriol (1983) 1.26

Chemical analysis of changes in membrane composition during growth of Streptococcus pyogenes. Infect Immun (1979) 1.24

Infectious crystalline keratopathy. Role of nutritionally variant streptococci and other bacterial factors. Ophthalmology (1991) 1.23

Enzyme-linked immunosorbent assay for the detection of antibodies to nutritionally variant streptococci in patients with endocarditis. J Infect Dis (1986) 1.20

Properties and kinetic analysis of UDP-glucose dehydrogenase from group A streptococci. Irreversible inhibition by UDP-chloroacetol. J Biol Chem (1997) 1.17

Molecular characterization of hasC from an operon required for hyaluronic acid synthesis in group A streptococci. Demonstration of UDP-glucose pyrophosphorylase activity. J Biol Chem (1995) 1.16

Quantitative immunoelectrophoretic analysis of Streptococcus pyogenes membrane. Infect Immun (1979) 1.13

Nutritionally variant streptococcal serotype I antigen. Characterization as a lipid-substituted poly(ribitol phosphate). J Immunol (1988) 1.02

Analysis of adherence of Streptococcus defectivus and endocarditis-associated streptococci to extracellular matrix. Infect Immun (1991) 0.96

Role of culture conditions and immunization in experimental nutritionally variant streptococcal endocarditis. Infect Immun (1985) 0.96

Quantitative analysis of cell walls of nutritionally variant streptococci grown under various growth conditions. Infect Immun (1985) 0.95

Identification of bacterial antigens in circulating immune complexes of infective endocarditis. J Clin Invest (1982) 0.94

Serial studies on circulating immune complexes in post-streptococcal sequelae. Clin Exp Immunol (1978) 0.93

Immunological studies of post-streptococcal sequelae: serological studies with an extracellular protein associated with nephritogenic streptococci. Clin Exp Immunol (1983) 0.88

Purification of serotype I antigen from nutritionally variant streptococci. Infect Immun (1988) 0.88

Immunological studies of post-streptococcal sequelae. Evidence for presence of streptococcal antigens in circulating immune complexes. J Clin Invest (1984) 0.87

Solubilization of hyaluronic acid synthetic activity from streptococci and its activation with phospholipids. J Biol Chem (1986) 0.85

Effects of penicillin on group A streptococci: loss of viability appears to precede stimulation of release of lipoteichoic acid. Antimicrob Agents Chemother (1981) 0.84

Identification of the surface component of Streptococcus defectivus that mediates extracellular matrix adherence. Infect Immun (1993) 0.83

Characterization of emb, a gene encoding the major adhesin of Streptococcus defectivus. Infect Immun (1999) 0.83

Lymphocytes binding C-reactive protein and streptococcal membranes in acute rheumatic fever. J Lab Clin Med (1980) 0.78

Purification and characterization of Streptococcus adjacens (nutritionally variant Streptococcus serotype II) group antigen. Infect Immun (1991) 0.77

Characterization of the Streptococcus adjacens group antigen structure. J Bacteriol (1992) 0.75

Inverse correlation in nutritionally variant streptococci between the production of bacteriolytic activity and sensitivity to a Streptococcus pyogenes bacteriocinlike inhibitory substance. J Clin Microbiol (1991) 0.75

Changes in T-lymphocyte subsets during acute rheumatic fever. J Clin Immunol (1982) 0.75

Evaluation of the immune response in protection against experimental Streptococcus defectivus endocarditis. J Lab Clin Med (1991) 0.75